|Post IPO Valuation|
|Phone||1 (862) 261-7488|
|Forest Laboratories, 2/2014||$25B|
|Warner Chilcott, 5/2013||$8.5B|
Actavis plc (NYSE: ACT) is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products.
The Company has global headquarters in Dublin, Ireland and Administrative Headquarters in Parsippany, New Jersey, USA.